Cargando…

Personalized Diagnosis and Therapy for Multiple Sclerosis

Detalles Bibliográficos
Autor principal:	Ramo-Tello, Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224658/ https://www.ncbi.nlm.nih.gov/pubmed/35743801 http://dx.doi.org/10.3390/jpm12061017

Ejemplares similares

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers
por: Ortega-Hernandez, Oscar-Danilo, et al.
Publicado: (2023)

Cryopreserved vitamin D(3)-tolerogenic dendritic cells pulsed with autoantigens as a potential therapy for multiple sclerosis patients
por: Mansilla, María José, et al.
Publicado: (2016)

Multiple Sclerosis: Diagnosis, Management, and Future Opportunities
por: Maida, Elisabetta, et al.
Publicado: (2023)

Combined Therapy of Vitamin D3-Tolerogenic Dendritic Cells and Interferon-β in a Preclinical Model of Multiple Sclerosis
por: Quirant-Sánchez, Bibiana, et al.
Publicado: (2021)

Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey
por: Tumani, Hayrettin, et al.
Publicado: (2023)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Editorial of Special Issue “Multiple Sclerosis: Diagnosis and Treatment II”
por: Rivera, Victor M.
Publicado: (2021)

Paving the way towards an effective treatment for multiple sclerosis: advances in cell therapy
por: Mansilla, M. J., et al.
Publicado: (2021)

Characterization of recent thymic emigrants (RTEs), transitional B and Th17 cells in multiple sclerosis (MS)
por: Teniente-Serra, Aina, et al.
Publicado: (2011)

Multiple Sclerosis
por: Ramagopalan, Sreeram, et al.
Publicado: (2011)

Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients
por: Grau-López, Laia, et al.
Publicado: (2012)

The Perspectives of Mesenchymal Stem Cell Therapy in the Treatment of Multiple Sclerosis
por: Naderi, Nima
Publicado: (2015)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies
por: Sancho-Saldaña, Agustín, et al.
Publicado: (2022)

Multiples sclerosis in India
por: Khadilkar, Satish V.
Publicado: (2015)

Multiple Sclerosis in India
por: Goyal, Vinay
Publicado: (2018)

Molecular Research in Multiple Sclerosis
por: Fucito, Maurine, et al.
Publicado: (2022)

Outcome Measures in Multiple Sclerosis
por: Bermel, Robert, et al.
Publicado: (2014)

IL-11 in multiple sclerosis
por: Zhang, Xin, et al.
Publicado: (2015)

Advances in Multiple Sclerosis 2017
por: Göbel, Kerstin, et al.
Publicado: (2018)

MAP7 and MUCL1 Are Biomarkers of Vitamin D3-Induced Tolerogenic Dendritic Cells in Multiple Sclerosis Patients
por: Navarro-Barriuso, Juan, et al.
Publicado: (2019)

Differential Diagnosis of Pediatric Multiple Sclerosis
por: Galardi, Maria Milagros, et al.
Publicado: (2019)

Vaccine hesitancy in people with multiple sclerosis
por: Lechner-Scott, Jeannette S, et al.
Publicado: (2022)

Multiple Sclerosis: From Molecules to Treatment
por: Broadley, Simon A
Publicado: (2013)

Improving communication with multiple sclerosis patients
por: Alroughani, Raed A.
Publicado: (2015)

Sequencing the immunopathologic heterogeneity in multiple sclerosis
por: Antel, Jack P, et al.
Publicado: (2015)

Multiple Sclerosis, Viruses, and New Vaccines
por: Maple, Peter A. C.
Publicado: (2021)

Digital Innovation in Multiple Sclerosis Management
por: Ziemssen, Tjalf, et al.
Publicado: (2021)

Molecule of the month: miRNA and Multiple Sclerosis
por: Shapshak, Paul
Publicado: (2013)

Neuropsychological Features of Multiple Sclerosis: Impact and Rehabilitation
por: Messinis, Lambros, et al.
Publicado: (2018)

Prospects of siponimod in secondary progressive multiple sclerosis
por: McGinley, Marisa, et al.
Publicado: (2018)

The Long Road of Immunotherapeutics against Multiple Sclerosis †
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

Cellular and Molecular Mechanisms in the Pathogenesis of Multiple Sclerosis
por: Wan, Edwin C. K.
Publicado: (2020)

Advances in Multiple Sclerosis Research–Series I
por: Apostolopoulos, Vasso, et al.
Publicado: (2020)

The relationship between multiple sclerosis and neuropsychiatric syndromes
por: McLoughlin, James, et al.
Publicado: (2017)

Response of the multiple sclerosis community to COVID-19
por: Ciccarelli, Olga, et al.
Publicado: (2020)

Management of Fatigue in Persons with Multiple Sclerosis
por: Khan, Fary, et al.
Publicado: (2014)

Amyotrophic Lateral Sclerosis: Precise Diagnosis and Individualized Treatment
por: Tao, Qing-Qing, et al.
Publicado: (2017)

The differential diagnosis of multiple sclerosis
por: Miller, David, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_q2cejp82ikgmq25mn2h5c2vs9m